News

BioArctic receives additional grant from Vinnova for a collaborative research project concerning antibody-based PET imaging for Alzheimer´s disease

November 21, 2017 - News

The grant of SEK 150, 000 from Vinnova will be used for a development of a regulatory plan and to evaluate the commercial potential of the ...

BioArctic strengthens Regulatory Affairs, employs Nora Sjödin

September 25, 2017 - News

BioArctic AB has employed Nora Sjödin as responsible for Regulatory Affairs. She takes up her duties in the company today.

September – the World Alzheimer’s Month

September 16, 2017 - News

Every fifth second someone in the world develops Alzheimer’s disease. There is a huge need for more research and effective treatments. September 2017 marks the sixth ...

BioArctic AB: Extraordinary General Meeting on September 4, 2017

September 5, 2017 - News

Election of new board member and new Chairman of the Board: The General Meeting resolved to appoint Eugen Steiner to new board member for the period ...

BioArctic to present poster and participate in round table discussion at international conference on Parkinson’s disease

August 29, 2017 - News

BioArctic will participate at the scientific meeting “20 years of alpha-synuclein in Parkinson’s Disease and related synucleinopathies: from the bedside to the bench and back to ...

Jan Mattsson employed as CFO

August 14, 2017 - News

Effective August 1, Jan Mattsson is employed by BioArctic as CFO. He has been working as CFO in the company as a consultant since February 2017.

BioArctic receives a grant from Vinnova / Medtech4Health for its quality management system work

April 4, 2017 - News

BioArctic has received a grant of 200 000 SEK from Vinnova (Sweden’s Innovation Agency) and Medtech4Health for the company’s quality management system work. The grant is ...

BioArctic to present two posters at the International Conference on Alzheimer’s and Parkinson’s Diseases

March 21, 2017 - News

BioArctic will participate at the 13th International Conference on Alzheimer’s and Parkinson’s Diseases in Vienna, Austria. The conference is focusing on mechanisms, clinical strategies, and promising ...

BioArctic receives a grant of half a million SEK from Vinnova for a collaborative research project concerning commercial potential of antibody-based PET imaging

March 16, 2017 - News

BioArctic is developing disease modifying treatment for Alzheimer’s disease. One major challenge is the limitations of biomarkers reflecting disease pathology, stage and severity. Thus, there is ...

Granted patent in the US for BAN2401 Backup drug candidate for Alzheimer’s disease which further strengthens BioArctic’s IP position

March 15, 2017 - News

On February 21, 2017, the US Patent Office granted BioArctic a patent (Patent No. US 9, 573, 994 B2) for the company’s antibody BAN2401 Backup for ...